| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACTN4
|
actinin, alpha 4
|
|
ADAM3A
|
ADAM metallopeptidase domain 3A (pseudogene)
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRM1
|
adhesion regulating molecule 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANOS1
|
anosmin 1
|
|
ANXA7
|
annexin A7
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
AR
|
androgen receptor
|
|
ARHGAP5
|
Rho GTPase activating protein 5
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARPC1A
|
actin related protein 2/3 complex, subunit 1A, 41kDa
|
|
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATXN2
|
ataxin 2
|
|
AURKA
|
aurora kinase A
|
|
AURKC
|
aurora kinase C
|
|
BCAS2
|
breast carcinoma amplified sequence 2
|
|
BCAS4
|
breast carcinoma amplified sequence 4
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLNK
|
B-cell linker
|
|
BLVRA
|
biliverdin reductase A
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C3
|
complement component 3
|
|
CAAP1
|
caspase activity and apoptosis inhibitor 1
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CBX2
|
chromobox homolog 2
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNL1
|
cyclin L1
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD28
|
CD28 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD70
|
CD70 molecule
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC16
|
cell division cycle 16
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC7
|
cell division cycle 7
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEP76
|
centrosomal protein 76kDa
|
|
CFHR1
|
complement factor H-related 1
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
CNKSR3
|
CNKSR family member 3
|
|
CPM
|
carboxypeptidase M
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
|
CREBBP
|
CREB binding protein
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTTN
|
cortactin
|
|
CUL4A
|
cullin 4A
|
|
CUL7
|
cullin 7
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DDT
|
D-dopachrome tautomerase
|
|
DDX1
|
DEAD (Asp-Glu-Ala-Asp) box helicase 1
|
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6
|
|
DHFR
|
dihydrofolate reductase
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DLX4
|
distal-less homeobox 4
|
|
DMD
|
dystrophin
|
|
DNM3
|
dynamin 3
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DPP3
|
dipeptidyl-peptidase 3
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EDN3
|
endothelin 3
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H
|
|
EIF5A2
|
eukaryotic translation initiation factor 5A2
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB4
|
EPH receptor B4
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV1
|
ets variant 1
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FNDC3B
|
fibronectin type III domain containing 3B
|
|
FRA11F
|
fragile site, aphidicolin type, common, fra(11)(q14.2)
|
|
FREM1
|
FRAS1 related extracellular matrix 1
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FUS
|
FUS RNA binding protein
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLDC
|
glycine dehydrogenase (decarboxylating)
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLO1
|
glyoxalase I
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAS
|
GNAS complex locus
|
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2
|
|
GPAA1
|
glycosylphosphatidylinositol anchor attachment 1
|
|
GPC5
|
glypican 5
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HAUS6
|
HAUS augmin-like complex, subunit 6
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HOXC13
|
homeobox C13
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFNA1
|
interferon, alpha 1
|
|
IFRD1
|
interferon-related developmental regulator 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker)
|
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker)
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL33
|
interleukin 33
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6R
|
interleukin 6 receptor
|
|
IRF9
|
interferon regulatory factor 9
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRS4
|
insulin receptor substrate 4
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KHK
|
ketohexokinase (fructokinase)
|
|
KIAA0196
|
KIAA0196
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLHDC8B
|
kelch domain containing 8B
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHFP
|
lipoma HMGIC fusion partner
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LRRN3
|
leucine rich repeat neuronal 3
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MARK4
|
MAP/microtubule affinity-regulating kinase 4
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFHAS1
|
malignant fibrous histiocytoma amplified sequence 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR145
|
microRNA 145
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR203A
|
microRNA 203a
|
|
MIR210
|
microRNA 210
|
|
MIR221
|
microRNA 221
|
|
MIR30A
|
microRNA 30a
|
|
MIR449A
|
microRNA 449a
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MME
|
membrane metallo-endopeptidase
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NANOG
|
Nanog homeobox
|
|
NBAS
|
neuroblastoma amplified sequence
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NEDD1
|
neural precursor cell expressed, developmentally down-regulated 1
|
|
NEK2
|
NIMA-related kinase 2
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOTCH1
|
notch 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUP214
|
nucleoporin 214kDa
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
ODC1
|
ornithine decarboxylase 1
|
|
ORAOV1
|
oral cancer overexpressed 1
|
|
OTOF
|
otoferlin
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX6
|
paired box 6
|
|
PAX7
|
paired box 7
|
|
PAX9
|
paired box 9
|
|
PDCD10
|
programmed cell death 10
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PEG10
|
paternally expressed 10
|
|
PHB
|
prohibitin
|
|
PHC3
|
polyhomeotic homolog 3 (Drosophila)
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP
|
prolactin-induced protein
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PIP4K2B
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLK1
|
polo-like kinase 1
|
|
PLK4
|
polo-like kinase 4
|
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPFIA1
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP2R1B
|
protein phosphatase 2, regulatory subunit A, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRNP
|
prion protein
|
|
PROM1
|
prominin 1
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRRC2C
|
proline-rich coiled-coil 2C
|
|
PRUNE
|
prune exopolyphosphatase
|
|
PSAP
|
prosaposin
|
|
PSMC6P1
|
proteasome 26S subunit, ATPase, 6 pseudogene 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
RAB43
|
RAB43, member RAS oncogene family
|
|
RAD51
|
RAD51 recombinase
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RECQL4
|
RecQ protein-like 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RET
|
ret proto-oncogene
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
RGSL1
|
regulator of G-protein signaling like 1
|
|
RHD
|
Rh blood group, D antigen
|
|
RHOA
|
ras homolog family member A
|
|
RIC1
|
RAB6A GEF complex partner 1
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RNF20
|
ring finger protein 20, E3 ubiquitin protein ligase
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPSA
|
ribosomal protein SA
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SCYL1
|
SCY1-like 1 (S. cerevisiae)
|
|
SEPT9
|
septin 9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGPL1
|
sphingosine-1-phosphate lyase 1
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SHOX2
|
short stature homeobox 2
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC26A5
|
solute carrier family 26 (anion exchanger), member 5
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SPECC1L
|
sperm antigen with calponin homology and coiled-coil domains 1-like
|
|
SPECC1L-ADORA2A
|
SPECC1L-ADORA2A readthrough (NMD candidate)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STK38
|
serine/threonine kinase 38
|
|
STMN1
|
stathmin 1
|
|
STOML3
|
stomatin (EPB72)-like 3
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
TBX1
|
T-box 1
|
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFDP1
|
transcription factor Dp-1
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
TIPE2
|
TNF alpha induced protein 8 like 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TMEM243
|
transmembrane protein 243, mitochondrial
|
|
TMSB10
|
thymosin beta 10
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPPP3
|
tubulin polymerization-promoting protein family member 3
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TYMS
|
thymidylate synthetase
|
|
UBE4B
|
ubiquitination factor E4B
|
|
USO1
|
USO1 vesicle transport factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VGLL3
|
vestigial-like family member 3
|
|
VWF
|
von Willebrand factor
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC6BP1
|
XRCC6 binding protein 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YEATS4
|
YEATS domain containing 4
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZNF217
|
zinc finger protein 217
|
|
ZNF703
|
zinc finger protein 703
|
